skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: My understanding is that both GH (Guardant Health) and BYND (Beyond Meat) of these are expensive stocks priced a lofty levels. However, based on the comments I have seen, 5i seems to be positive on GH but negative on BYND. I know these are different sectors and very different companies, but don't think you that the "expensive" label would apply to both?
Read Answer Asked by Mike on July 09, 2019
Q: I'm thinking about selling a position in EFN with a 5% weighting in a RESP with a 5 year time horizon and replacing it with either CNR, NTR or BIP.UN. Another newsletter is big on these 3 names for longer term holds. Thoughts?
Read Answer Asked by Chris on July 09, 2019
Q: I bought FSZ in early May looking for a lower risk financial company to add to my portfolio of BAM, TD, BNS, SLF, GSY.
FSZ is now down 10% since purchase and still slowly dropping. Would you suggest I sell and move on and add to one of my other financials or add something else, or hold on to FSZ. If another financial, what would you suggest.
I am still looking for a lower risk financial equity holding.
Read Answer Asked by David on July 09, 2019
Q: HI 5i team, recently you mentioned couple companies with a growth rate of 50%. Do you mean revenue or earning or some measure ? Will you please list top 20 Canadian companies with such growth prospect. Thanks.
Read Answer Asked by victor on July 09, 2019
Q: Good morning 5i, I am still plodding along with asset allocator. I have only Weed left in healthcare having sold GUD, and COV. I need 9% so another 7% after WEED. Happy to buy in $US or $Cdn and looking at XHC, IHI, PFE, ZTS. I appreciate your input. Regards, Ted
Read Answer Asked by Ted on July 09, 2019
Q: I have FAH and FIH in a long term RRSP. I believe in the long term growth of these regions and I’m cautiously hopeful Mr Watsa and team are making sound PE investments to try to benefit from regional growth. But I find them tricky to assess because of the fees and the multi-asset PE structure. Can you provide your view on the financial performance of these companies? I would also appreciate your thoughts on whether you’d consider topping up a relatively small position. Please deduct two questions and deal with each separately. Thanks!
Read Answer Asked by Chris on July 09, 2019
Q: Good morning team,
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.

“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.

https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html

Comments please,
Thank you!
Read Answer Asked by Silvia on July 09, 2019
Q: Hi 5i team, if I remember right you do caution small investor like us buy and sell in the first hour of each trading day. Is there any reason behind this practice ?
Read Answer Asked by victor on July 09, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!